The Innovative Medicines Initiative (IMI) launched its 11th call for proposals on December 11th, 2013. The call features eight topics including the «European platform for proof of concept for prevention in Alzheimers Disease» (EPOC-AD).
EPOC-AD calls for greater cooperation and collaboration between academia, government and industry to enhance the drug development process.
The project would create a precompetitive space to enable collaboration for optimising patient selection, clinical trials methodologies and candidate therapies, as well as conducting adaptive clinical trials that will produce the greatest likelihood of success.